BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9824154)

  • 1. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Cayrol C; Ducommun B
    Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
    Cayrol C; Knibiehler M; Ducommun B
    Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
    Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome.
    Touitou R; Richardson J; Bose S; Nakanishi M; Rivett J; Allday MJ
    EMBO J; 2001 May; 20(10):2367-75. PubMed ID: 11350925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
    Wu Y; Luo H; Kanaan N; Wu J
    J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
    Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
    Le NT; Richardson DR
    Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
    Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
    Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
    Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells.
    Lu Y; Tatsuka M; Takebe H; Yagi T
    Mol Carcinog; 2000 Sep; 29(1):1-7. PubMed ID: 11020241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
    Law M; Forrester E; Chytil A; Corsino P; Green G; Davis B; Rowe T; Law B
    Cancer Res; 2006 Jan; 66(2):1070-80. PubMed ID: 16424043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
    Boulaire J; Fotedar A; Fotedar R
    Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction.
    Prabhu NS; Blagosklonny MV; Zeng YX; Wu GS; Waldman T; El-Deiry WS
    Clin Cancer Res; 1996 Jul; 2(7):1221-9. PubMed ID: 9816291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
    Waga S; Hannon GJ; Beach D; Stillman B
    Nature; 1994 Jun; 369(6481):574-8. PubMed ID: 7911228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.
    Coleman ML; Marshall CJ; Olson MF
    EMBO J; 2003 May; 22(9):2036-46. PubMed ID: 12727871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
    Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
    Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.